These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


143 related items for PubMed ID: 10839624

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Loop domain peptides from the SOS ras-guanine nucleotide exchange protein, identified from molecular dynamics calculations, strongly inhibit ras signaling.
    Chie L, Friedman FK, Duncan T, Chen JM, Chung D, Pincus M.
    Protein J; 2004 Apr; 23(3):229-34. PubMed ID: 15200054
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Molecular dynamics analysis of the structures of ras-guanine nucleotide exchange protein (SOS) bound to wild-type and oncogenic ras-p21. Identification of effector domains of SOS.
    Chen JM, Friedman FK, Hyde MJ, Monaco R, Pincus MR.
    J Protein Chem; 1999 Nov; 18(8):867-74. PubMed ID: 10839623
    [Abstract] [Full Text] [Related]

  • 7. Plasmid expression of a peptide that selectively blocks oncogenic ras-p21-induced oocyte maturation.
    Kovac C, Clie L, Morin J, Friedman FK, Robinson R, Chung DL, Kanovsky M, Flom J, Brandt-Rauf PW, Yamaizumi Z, Michl J, Pincus MR.
    Cancer Chemother Pharmacol; 2001 Jul; 48(1):9-14. PubMed ID: 11488531
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Identification of the site of inhibition of mitogenic signaling by oncogenic ras-p21 by a ras effector peptide.
    Chie L, Friedman FK, Kung HF, Lin MC, Chung D, Pincus MR.
    J Protein Chem; 2002 Jul; 21(5):367-70. PubMed ID: 12206511
    [Abstract] [Full Text] [Related]

  • 11. Development of new anti-cancer peptides from conformational energy analysis of the oncogenic ras-p21 protein and its complexes with target proteins.
    Pincus MR.
    Front Biosci; 2004 Sep 01; 9():3486-509. PubMed ID: 15353372
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evidence that oocyte maturation induced by an oncogenic ras-p21 protein and insulin is mediated by overlapping yet distinct mechanisms.
    Chung DL, Joran A, Friedman F, Robinson R, Brandt-Rauf PW, Weinstein IB, Ronai Z, Baskin L, Dykes DC, Murphy RB.
    Exp Cell Res; 1992 Dec 01; 203(2):329-35. PubMed ID: 1459198
    [Abstract] [Full Text] [Related]

  • 14. Identification, using molecular dynamics, of an effector domain of the ras-binding domain of the raf-p74 protein that is uniquely involved in oncogenic ras-p21 signaling.
    Chen JM, Rijhwani K, Friedman FK, Hyde MJ, Pincus MR.
    J Protein Chem; 2000 Oct 01; 19(7):545-51. PubMed ID: 11233167
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the average structures, from molecular dynamics, of complexes of GTPase activating protein (GAP) with oncogenic and wild-type ras-p21: identification of potential effector domains.
    Chen JM, Friedman FK, Brandt-Rauf PW, Pincus MR, Chie L.
    J Protein Chem; 2002 Jul 01; 21(5):349-59. PubMed ID: 12206509
    [Abstract] [Full Text] [Related]

  • 16. A peptide from the GAP-binding domain of the ras-p21 protein and azatyrosine block ras-induced maturation of Xenopus oocytes.
    Chung DL, Brandt-Rauf P, Murphy RB, Nishimura S, Yamaizumi Z, Weinstein IB, Pincus MR.
    Anticancer Res; 1991 Jul 01; 11(4):1373-8. PubMed ID: 1746893
    [Abstract] [Full Text] [Related]

  • 17. The dual-specificity kinases, TOPK and DYRK1A, are critical for oocyte maturation induced by wild-type--but not by oncogenic--ras-p21 protein.
    Qu Y, Adler V, Izotova L, Pestka S, Bowne W, Michl J, Boutjdir M, Friedman FK, Pincus MR.
    Front Biosci; 2007 Sep 01; 12():5089-97. PubMed ID: 17569632
    [Abstract] [Full Text] [Related]

  • 18. A protein methyl transferase, PRMT5, selectively blocks oncogenic ras-p21 mitogenic signal transduction.
    Chie L, Cook JR, Chung D, Hoffmann R, Yang Z, Kim Y, Pestka S, Pincus MR.
    Ann Clin Lab Sci; 2003 Sep 01; 33(2):200-7. PubMed ID: 12817625
    [Abstract] [Full Text] [Related]

  • 19. Differences in patterns of activation of MAP kinases induced by oncogenic ras-p21 and insulin in oocytes.
    Ranginwale M, Smith S, Flom J, Chie L, Kanovsky M, Chung D, Friedman FK, Robinson RC, Brandt-Rauf PW, Yamaizumi Z, Michl J, Pincus MR.
    Exp Cell Res; 2001 Sep 10; 269(1):162-9. PubMed ID: 11525649
    [Abstract] [Full Text] [Related]

  • 20. Induction of oocyte maturation by jun-N-terminal kinase (JNK) on the oncogenic ras-p21 pathway is dependent on the raf-MEK signal transduction pathway.
    Chie L, Amar S, Kung HF, Lin MC, Chen H, Chung DL, Adler V, Ronai Z, Friedman FK, Robinson RC, Kovac C, Brandt-Rauf PW, Yamaizumi Z, Michl J, Pincus MR.
    Cancer Chemother Pharmacol; 2000 Sep 10; 45(6):441-9. PubMed ID: 10854130
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.